Immunitybio News - November 2, 2026

🔴 Immunitybio is trading 4.04% down today as biotech ETF XBI falls 2.39%

Immunitybio is trading 4.04% down at $7.96 as broad biotech weakness weighs on shares. - The sector ETF XBI is down 2.39%, and the provided market data also...

Immunitybio Inc Q3 2026 Earnings Preview: What Analysts Expect on November 03, 2026

Analysts expect ImmunityBio to report Q3 2026 revenue of $59.23 million and a consensus EPS of -$0.07, with shares currently trading at $8.53 against an...